Key Points
-
Sexual problems, particularly erectile dysfunction, are more common in men with HIV than in the general population
-
Sexual dysfunction is often overlooked in men with HIV due to the reluctance of physicians or their patients to address sex-related issues
-
The clinical management of male sexual dysfunction requires a multidisciplinary approach involving specialists in infectious diseases and sexual medicine
-
Factors related to HIV infection, such as fear of virus transmission, body image change, HIV-related comorbidities, stigma, obligatory use of condoms, and safer sex should be considered
-
The treatment should take into account the risk of HIV transmission to partners, and always be accompanied by counselling on safe sexual practices
Abstract
Sexual dysfunction in men with HIV is often overlooked by clinicians owing to many factors, including the taboo of sexuality. The improved life expectancy of patients with HIV requires physicians to consider their general wellbeing and sexual health with a renewed interest. However, data on sexual dysfunction in those with HIV are scarce. Erectile dysfunction (ED) is the most common sexual dysfunction in men, with a prevalence of ∼30–50% and is frequent even in men <40 years of age. HIV infection itself is the strongest predictor of ED, and many factors related to the infection—fear of virus transmission, changes in body image, HIV-related comorbidities, infection stigma, obligatory condom use—all impair erectile function. The diagnosis and treatment of sexual dysfunction is based on a multidisciplinary approach, which involves specialists in both infectious diseases and sexual medicine. Particular attention should be paid to the promotion of safer sex in these patients. This Review, describes the issues surrounding sexual dysfunction in men with HIV and aims to provide clinical advice for the physician treating these patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Samaras, K. Endocrine disease in HIV infection. Best Pract. Res. Clin. Endocrinol. Metab. 25, vii–viii (2011).
Sellmeyer, D. E. & Grunfeld, C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr. Rev. 17, 518–532 (1996).
Palella, F. J. Jr et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N. Engl. J. Med. 338, 853–860 (1998).
Zirilli, L. et al. Hypopituitarism and HIV-infection: a new comorbidity in the HAART era? J. Endocrinol. Invest. 31, 33–38 (2008).
Brown, T. T. The effects of HIV-1 infection on endocrine organs. Best Pract. Res. Clin. Endocrinol. Metab. 25, 403–413 (2011).
Collazos, J. Sexual dysfunction in the highly active antiretroviral therapy era. AIDS Rev. 9, 237–245 (2007).
Neuhaus, J. et al. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS 24, 697–706 (2010).
Cotter, A. G. & Powderly, W. G. Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity. Best Pract. Res. Clin. Endocrinol. Metab. 25, 501–515 (2011).
Zirilli, L. et al. GH response to GHRH plus arginine (GHRH+ARG) is impaired in lipoatrophic women with human immunodeficiency virus compared with controls. Eur. J. Endocrinol. 166, 415–424 (2012).
Rochira, V. et al. Premature decline of serum total testosterone in HIV-infected men in the HAART-era. PLoS ONE 6, e28512 (2011).
Luzi, K. et al. Body image is a major determinant of sexual dysfunction in stable HIV-infected women. Antivir. Ther. 14, 85–92 (2009).
Guaraldi, G. et al. Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophy. Antivir. Ther. 12, 1059–1065 (2007).
Scanavino Mde, T. Sexual dysfunctions of HIV-positive men: Associated factors, pathophysiology issues, and clinical management. Adv. Urol. 2011, 854792 (2011).
Rochira, V. et al. Sex steroids and sexual desire mechanism. J. Endocrinol. Invest. 26, 29–36 (2003).
Carani, C., Rochira, V. & Granata, A. R. M. in Oxford Textbook of Endocrinology and Diabetes (eds Wass, J. A. & Stewart. P. M.) 1449–1458 (Oxford University Press, 2011).
Lewis, R. W. et al. Definitions/epidemiology/risk factors for sexual dysfunction. J. Sex. Med. 7, 1598–1607 (2010).
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J. & McKinlay, J. B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. 151, 54–61 (1994).
Laumann, E. O., Paik, A. & Rosen, R. C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281, 537–544 (1999).
Braun, M. et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int. J. Impot. Res. 12, 305–311 (2000).
Chew, K. K., Stuckey, B., Bremner, A., Earle, C. & Jamrozik, K. Male erectile dysfunction: its prevalence in western Australia and associated sociodemographic factors. J. Sex. Med. 5, 60–69 (2008).
Ghalayini, I. F. et al. Erectile dysfunction in a Mediterranean country: results of an epidemiological survey of a representative sample of men. Int. J. Impot. Res. 22, 196–203 (2010).
Christensen, B. S. et al. Sexual dysfunctions and difficulties in Denmark: prevalence and associated sociodemographic factors. Arch. Sex. Behav. 40, 121–132 (2011).
Newshan, G., Taylor, B. & Gold, R. Sexual functioning in ambulatory men with HIV/AIDS. Int. J. STD AIDS. 9, 672–676 (1998).
Rosen, R. C., Cappelleri, J. C. & Gendrano, N. 3rd. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int. J. Impot. Res. 14, 226–244 (2002).
Jones, M., Klimes, I. & Catalan, J. Psychosexual problems in people with HIV infection: controlled study of gay men and men with haemophilia. AIDS Care 6, 587–593 (1994).
Tindall, B., Forde, S., Goldstein, D., Ross, M. W. & Cooper, D. A. Sexual dysfunction in advanced HIV disease. AIDS Care 6, 105–107 (1994).
Hijazi, L., Nandwani, R. & Kell, P. Medical management of sexual difficulties in HIV-positive individuals. Int. J. STD AIDS 13, 587–592 (2002).
Martínez, E., Collazos, J., Mayo, J. & Blanco, M. S. Sexual dysfunction with protease inhibitors. Lancet 353, 810–811 (1999).
Schrooten, W. et al. Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS 15, 1019–1023 (2001).
Sollima, S. et al. Protease inhibitors and erectile dysfunction. AIDS 15, 2331–2333 (2001).
Collazos, J., Martínez, E., Mayo, J. & Ibarra, S. Sexual dysfunction in HIV-infected patients treated with highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 31, 322–326 (2002).
Colson, A. E. et al. Male sexual dysfunction associated with antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 30, 27–32 (2002).
Lallemand, F., Salhi, Y., Linard, F., Giami, A. & Rozenbaum, W. Sexual dysfunction in 156 ambulatory HIV-infected men reciving highly active antiretroviral therapy combinations with and without protease inhibitors. J. Aquir. Immune Defic. Syndr. 30, 187–190 (2002).
Cove, J. & Petrak, J. Factors associated with sexual problems in HIV-positive gay men. Int. J. STD AIDS 15, 732–736 (2004).
Ende, A. R., Lo Re, V. 3rd, DiNubile, M. J. & Mounzer, K. Erectile dysfunction in an urban HIV-positive population. AIDS Patient Care STDS 20, 75–78 (2006).
Asboe, D. et al. Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. AIDS Care 19, 955–965 (2007).
Crum-Cianflone, N. F. et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS 21, 9–19 (2007).
Moreno-Pérez, O. et al. Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors. AIDS 24, 255–264 (2010).
Guaraldi, G. et al. Erectile dysfunction is not a mirror of endothelial dysfunction in HIV-infected patients. J. Sex. Med. 9, 1114–1121 (2012).
Zona, S. et al. Erectile dysfunction is more common in young to middle-aged HIV-infected men than in HIV-uninfected men. J. Sex. Med. 9, 1923–1930 (2012).
Hart, T. A. et al. The cumulative effects of medication use, drug use, and smoking on erectile dysfunction among men who have sex with men. J. Sex. Med. 9, 1106–1113 (2012).
De Ryck, I. et al. Sexual satisfaction among men living with HIV in Europe. AIDS Behav. 16, 225–230 (2012).
Vansintejan, J., Janssen, J., Van De Vijver, E., Vandevoorde, J. & Devroey, D. The Gay Men Sex Studies: prevalence of sexual dysfunctions in Belgian HIV(+) gay men. HIV AIDS (Auckl.) 5, 89–96 (2013).
Wang, Q. et al. The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study. Antivir. Ther. 18, 337–344 (2013).
Fakoya, A. et al. British HIV Association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection 2008. HIV Med. 9, 681–720 (2008).
Rhoden, E. L., Telöken, C., Sogari, P. R. & Vargas Souto, C. A. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int. J. Impot. Res. 14, 245–250 (2002).
Graham, C. A. et al. Erection loss in association with condom use among young men attending a public STI clinic: potential correlates and implications for risk behaviour. Sex Health 3, 255–260 (2006).
Basson, R. & Schultz, W. W. Sexual sequelae of general medical disorders. Lancet 369, 409–424 (2007).
Basson, R., Rees, P., Wang, R., Montejo, A. L. & Incrocci, L. Sexual function in chronic illness. J. Sex. Med. 7, 374–388 (2010).
Trotta, M. P., Ammassari, A., Murri, R., Monforte, A. D. & Antinori, A. Sexual dysfunction in HIV infection. Lancet 369, 905–906 (2007).
Reiss, P. P., Battegay, M., Clumeck, N., Mulcahy, F. & European AIDS Clinical Society (EACS) Executive Guidelines Members. EACS Guidelines [online], (2011).
Granata, A., Bancroft, J. & Del Rio, G. Stress and the erectile response to intracavernosal prostaglandin E1 in men with erectile dysfunction. Psychosom. Med. 57, 336–344 (1995).
Petrone, L. et al. Structured interview on erectile dysfunction (SIEDY): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction. Int. J. Impot. Res. 15, 210–220 (2003).
Guay, A. T. ED2: erectile dysfunction = endothelial dysfunction. Endocrinol. Metab. Clin. North. Am. 36, 453–463 (2007).
Corona, G. et al. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur. Urol. 50, 595–604 (2006).
Corona, G. et al. Is metabolic syndrome a useless category in subjects with high cardiovascular risk? Results from a cohort study in men with erectile dysfunction. J. Sex. Med. 8, 504–511 (2011).
Murri, R. et al. Nonnucleoside reverse transcriptase inhibitor-containing regimens are associated with increased satisfaction with sexual life. J. Acquir. Immune Defic. Syndr. 34, 532–534 (2003).
Guaraldi, G. et al. Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy. HIV Clin. Trials 7, 97–106 (2006).
Amini Lari, M., Parsa, N., Marzban, M., Shams, M. & Faramarzi, H. Depression, testosterone concentration, sexual dysfunction and methadone use among men with hypogonadism and HIV Infection. AIDS Behav. 16, 2236–2243 (2012).
Richardson, D., Lamba, H., Goldmeier, D., Nalabanda, A. & Harris, J., R. Factors associated with sexual dysfunction in men with HIV infection. Int. J. STD AIDS 17, 764–767 (2006).
Shindel, A. W., Horberg, M. A., Smith, J. F. & Breyer, B., N. Sexual dysfunction, HIV, and AIDS in men who have sex with men. AIDS Patient Care STDS 25, 341–349 (2011).
Dirks, H. et al. Substance use and sexual risk behaviour among HIV-positive men who have sex with men in specialized out-patient clinics. HIV Med. 13, 533–540 (2012).
Bancroft, J., Carnes, L. & Janssen, E. Unprotected anal intercourse in HIV-positive and HIV-negative gay men: the relevance of sexual arousability, mood, sensation seeking, and erectile problems. Arch. Sex. Behav. 34, 299–305 (2005).
Foresta, C. et al. Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart. Int. J. Androl. 32, 198–211 (2009).
Shamloul, R. & Ghanem, H. Erectile dysfunction. Lancet 381, 153–165 (2013).
Altman, D. et al. Men who have sex with men: stigma and discrimination. Lancet 380, 439–445 (2012).
Coyne, K. et al. The International Index of Erectile Function: development of an adapted tool for use in HIV-positive men who have sex with men. J. Sex. Med. 7, 769–774 (2010).
Sanders, S. A., Milhausen, R. R., Crosby, R. A., Graham, C. A. & Yarber, W. L. Do phosphodiesterase type 5 inhibitors protect against condom-associated erection loss and condom slippage? J. Sex. Med. 6, 1451–1456 (2009).
Granata, A. R., Rochira, V., Lerchl, A., Marrama, P. & Carani, C. Relationship between sleep-related erections and testosterone levels in men. J. Androl. 18, 522–527 (1997).
Lenzi, A. & Jannini, E. A. The andrologist from medicine of reproduction to sexual medicine: the Italian experience. Int. J. Androl. 28, 9–13 (2005).
Nettles, C. D., Benotsch, E. G. & Uban, K. A. Sexual risk behaviors among men who have sex with men using erectile dysfunction medictions. AIDS Patient Care STDS 23, 1017–1023 (2009).
Pescatori, E. S., Giammusso, B., Piubello, G., Gentile, V. & Farina, F. P. Journey into the realm of requests for help presented to sexual medicine specialists: introducing male sexual distress. J. Sex. Med. 4, 762–770 (2007).
Bechara, A., Casabè, A., De Bonis, W., Helien, A. & Bertolino, M. V. Recreational use of phosphodiesterase type 5 inhibitors by healthy young men. J. Sex. Med. 7, 3736–3742 (2010).
Richardson, D., Goldmeier, D., Bell, C. & Lamba, H. Do phosphodiesterase 5 inhibitors promote onward transmission of HIV in men who have sex with men? Sex. Transm. Infect. 83, 250 (2007).
Graham, N. A., Polles, A. & Gold, M. S. Performance enhancing, non-prescription use of erectile dysfunction medications. J. Addict. Dis. 25, 61–68 (2006).
Kell, P., Sadeghi-Nejad, H. & Price, D. An ethical dilemma: erectile dysfunction in the HIV-positive patient: to treat or not to treat. Int. J. STD AIDS 13, 355–357 (2002).
Sadeghi-Nejad, H. et al. Lecture 5: erectile dysfunction in the HIV-positive male: a review of medical, legal and ethical considerations in the age of oral pharmacotherapy. Int. J. Impot. Res. 3, S49–S53 (2000).
Rosen, R. C. et al. The Bolger conference on PDE-5 inhibition and HIV risk: implications for health policy and prevention. J. Sex. Med. 3, 960–975 (2006).
Romanelli, F. & Smith, K. M. Recreational use of sildenafil by HIV-positive and -negative homosexual/bisexual males. Ann. Pharmacother. 38, 1024–1030 (2004).
Rochira, V., Balestrieri, A., Madeo, B., Granata, A. R. & Carani, C. Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role of both testosterone and sildenafil on penile erections. J. Androl. 27, 165–175 (2006).
Gallego, L., Barreiro, P. & López-Ibor, J. J. Psychopharmacological treatments in HIV patients under antiretroviral therapy. AIDS Rev. 14, 101–111 (2012).
Lau, J. T., Kim, J. H. & Tsui, H. Y. Prevalence and sociocultural predictors of sexual dysfunction among Chinese men who have sex with men in Hong Kong. J. Sex. Med. 5, 2766–2779 (2008).
Shindel, A. W., Vittinghoff, E. & Breyer, B. N. Erectile dysfunction and premature ejaculation in men who have sex with men. J. Sex. Med. 9, 576–584 (2012).
Martin, J. & Volberding, P. HIV and premature aging: A field still in its infancy. Ann. Intern. Med. 153, 477–479 (2010).
Deeks, S. G. HIV infection, inflammation, immunosenescence, and aging. Annu. Rev. Med. 62, 141–155 (2011).
Marcus, E. N. Bones of contention: premature aging and bone loss emerge as new concerns with HIV. Posit. Aware 23, 28–29 (2011).
Guaraldi, G. et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin. Infect. Dis. 53, 1120–1126 (2011).
Sadeghi-Nejad, H. Special considerations in the management of erectile dysfunction in the HIV-positive patient. Curr. Sex. Health Rep. 1, 49–53 (2004).
World Health Organization. Defining sexual health: report of a technical consultation on sexual health [online], (2006).
Havlir, D. & Beyrer, C. The beginning of the end of AIDS? N. Engl. J. Med. 367, 685–687 (2012).
Korkes, F., Costa-Matos, A., Gasperini, R., Reginato, P. V. & Perez, M. D. Recreational use of PDE5 inhibitors by young healthy men: recognizing this issue among medical students. J. Sex. Med. 5, 2414–2418 (2008).
Somers, K. J. & Philbrick, K. L. Sexual dysfunction in the medically ill. Curr. Psychiatry Rep. 9, 247–254 (2007).
Acknowledgements
The authors thank Professor Paola Ugolini, Visiting Assistant Professor, Department of Romance Languages & Literatures, SUNY Buffalo, New York, USA for manuscript proofreading and editing.
Author information
Authors and Affiliations
Contributions
V. Rochira, D. Santi and G. Brigante researched data for the article. All authors contributed equally to the writing of the article and made substantial contribution to discussion of the content. V. Rochira and G. Guaraldi reviewed and edited the manuscript before publication.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Santi, D., Brigante, G., Zona, S. et al. Male sexual dysfunction and HIV—a clinical perspective. Nat Rev Urol 11, 99–109 (2014). https://doi.org/10.1038/nrurol.2013.314
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2013.314
This article is cited by
-
Hypogonadism and liver fibrosis in HIV-infected patients
Journal of Endocrinological Investigation (2021)
-
A new grounded theory model of sexual adjustment to HIV: facilitators of sexual adjustment and recommendations for clinical practice
BMC Infectious Diseases (2020)
-
Sexual dysfunction and male infertility
Nature Reviews Urology (2018)
-
Erectile Dysfunction Medication Prescription and Condomless Intercourse in HIV-Infected Men Who have Sex with Men in the United States
AIDS and Behavior (2017)
-
Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study
Osteoporosis International (2016)